5 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| DANA-FARBER CANCER INSTITUTE, INC. | 2 |
| DANA-FARBER CANCER INSTITUTE, INC. | 2 |
| Dina Stroopinsky | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18289568 | ANTIBODIES AGAINST ALK AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | WEIDNER, ADAM M | 1675 | Non-Final OA | Nov 05, 2023 |
| 18554429 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | Dina Stroopinsky | PIHONAK, SARAH | 1627 | Non-Final OA | Oct 10, 2023 |
| 18285413 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | DANA-FARBER CANCER INSTITUTE, INC. | DONOHUE, SEAN R | 1618 | Non-Final OA | Oct 03, 2023 |
| 18283264 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | DANA-FARBER CANCER INSTITUTE, INC. | BURKETT, DANIEL JOHN | 1624 | Non-Final OA | Sep 21, 2023 |
| 18031257 | GERMLINE BIOMARKERS OF CLINICAL RESPONSE AND BENEFIT TO IMMUNE CHECKPOINT INHIBITOR THERAPY | DANA-FARBER CANCER INSTITUTE, INC. | HINES, JANA A | 1645 | Non-Final OA | Apr 11, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial